Barclays PLC Portfolio Holdings

Barclays PLC

  • $436 Billion
  • Q2 2025

Barclays PLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $436 Billion distributed in 12350 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $17.4B, Nvidia Corp with a value of $15.9B, Apple Inc. with a value of $9.34B, Amazon Com Inc with a value of $7.98B, and Tesla, Inc. with a value of $6.51B.

Examining the 13F form we can see an increase of $184B in the current position value, from $252B to 436B.

Barclays PLC is based out at London, X0

Below you can find more details about Barclays PLC portfolio as well as his latest detailed transactions.

Portfolio value $436 Billion
ETFs: $158 Billion
Technology: $99.7 Billion
Consumer Cyclical: $34.9 Billion
Financial Services: $33.3 Billion
Communication Services: $27 Billion
Industrials: $20.8 Billion
Healthcare: $20 Billion
Consumer Defensive: $11.9 Billion
Other: $21.9 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$209M
$79,000 0.0% of portfolio
5,407
Q2 2025 Added 64.3%
Swvl Holdings Corp
-
$0 0.0% of portfolio
-
Q2 2022 New
$1.86B
$3.33 Million 0.0% of portfolio
66,415
Q2 2025 Added 26.31%
$3.87B
$387,000 0.0% of portfolio
9,965
Q2 2025 Added 10.55%
$2.82B
$7.91 Million 0.0% of portfolio
122,074
Q2 2025 Added 43.11%
Synchronoss Technologies Inc
-
$145,000 0.0% of portfolio
-
Q2 2025 Added 216.69%
$881M
$3.59 Million 0.0% of portfolio
382,966
Q2 2025 Added 91.49%
$6.43B
$14.4 Million 0.0% of portfolio
278,435
Q2 2025 Reduced 10.84%
System1 Inc
-
$1,000 0.0% of portfolio
-
Q2 2025 New
T1 Energy Inc
-
$230,000 0.0% of portfolio
-
Q2 2025 Added 65.68%
$749M
$121,000 0.0% of portfolio
33,324
Q2 2025 Reduced 0.53%
$294M
$468,000 0.0% of portfolio
46,220
Q2 2025 Reduced 22.73%
$41.1B
$24,000 0.0% of portfolio
1,577
Q2 2025 Reduced 4.66%
$7.68B
$4.39 Million 0.0% of portfolio
429,406
Q2 2025 Reduced 56.48%
$441M
$597,000 0.0% of portfolio
214,855
Q2 2025 Added 60.96%
$752M
$13 Million 0.0% of portfolio
1,532,953
Q2 2025 Reduced 3.81%
$937M
$10.6 Million 0.0% of portfolio
567,072
Q2 2025 Added 10.32%
Tandem Diabetes Care Inc
-
$1.96 Million 0.0% of portfolio
-
Q2 2025 Added 12.06%
$3.4B
$11 Million 0.0% of portfolio
359,897
Q2 2025 Added 23.41%
$798M
$710,000 0.0% of portfolio
138,650
Q2 2025 Added 119.97%
$696M
$540,000 0.0% of portfolio
75,900
Q2 2025 Added 30.85%
$1.9B
$5.17 Million 0.0% of portfolio
127,579
Q2 2025 Added 141.45%
$1.07B
$315,000 0.0% of portfolio
100,181
Q2 2025 Added 57.78%
$380M
$350,000 0.0% of portfolio
20,937
Q2 2025 Reduced 0.04%
Tat Technologies LTD
-
$5,000 0.0% of portfolio
-
Q1 2025 New
Taylor Devices Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 99.97%
$251M
$1.04 Million 0.0% of portfolio
450,501
Q2 2025 Reduced 36.46%
$14.9B
$9.65 Million 0.0% of portfolio
71,134
Q2 2025 Added 7.72%
$139M
$311,000 0.0% of portfolio
125,339
Q2 2025 Added 20.47%
Team Inc
-
$5.27 Million 0.0% of portfolio
-
Q2 2025 Reduced 2.0%
$16.3B
$17.6 Million 0.0% of portfolio
510,477
Q2 2025 Added 3.21%
Techtarget Inc
-
$412,000 0.0% of portfolio
-
Q2 2025 Added 49.3%
$22.5B
$18.2 Million 0.0% of portfolio
451,230
Q2 2025 Added 9.5%
$2.82B
$3.46 Million 0.0% of portfolio
44,781
Q2 2025 Added 65.03%
Tectonic Therapeutic Inc
-
$435,000 0.0% of portfolio
-
Q2 2025 Added 59.67%
Teekay Corporation LTD
-
$726,000 0.0% of portfolio
-
Q2 2025 Added 58.96%
Teekay Tankers LTD
-
$3 Million 0.0% of portfolio
-
Q2 2025 Added 78.25%
$4.38B
$8.19 Million 0.0% of portfolio
488,367
Q2 2025 Added 109.04%
$417M
$593,000 0.0% of portfolio
35,013
Q2 2025 Added 66.12%
$1.42B
$4.6 Million 0.0% of portfolio
528,258
Q2 2025 Added 18.03%
Teladoc Health Inc
-
$611,000 0.0% of portfolio
-
Q2 2025 Reduced 33.2%
$3.28B
$40,000 0.0% of portfolio
4,500
Q4 2022 New
$5.86B
$3.5 Million 0.0% of portfolio
29,613
Q2 2025 Reduced 85.02%
$21.1B
$14.7 Million 0.0% of portfolio
1,290,641
Q2 2025 Reduced 2.46%
$29.6B
$463,000 0.0% of portfolio
88,710
Q2 2025 Reduced 92.0%
$4.13B
$7.39 Million 0.0% of portfolio
207,815
Q2 2025 Reduced 73.79%
$385M
$1,000 0.0% of portfolio
25
Q1 2025 Reduced 68.75%
Telomir Pharmaceuticals Inc
-
$4,000 0.0% of portfolio
-
Q2 2025 Reduced 85.17%
$20.9B
$17.4 Million 0.0% of portfolio
1,082,475
Q2 2025 Added 97.87%

Summary

  • Portfolio
  • No. of Stocks 12,350
  • Current Value $436 Billion
  • Prior Value $252 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR/A
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email